Publications
33
Citations
494
Est. group size
~17
Recurring co-author estimate
Active years
18
Publishing since 2009
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 8 venues
- Interferon-γ induces combined pyroptotic angiopathy and APOL1 expression in human kidney disease
Cell Reports · 2024
- Direct Interaction Between CD34+ Hematopoietic Stem Cells and Mesenchymal Stem Cells Reciprocally Preserves Stemness
Cancers · 2024
- Direct Interaction Between CD34+ Hematopoietic Stem Cells and Mesenchymal Stem Cells Reciprocally Preserves Stemness
Preprints.org · 2024
- MO059: Trajectory Analysis of the Kidney Organoid Proteome Extends its Modelling Potential of Disease
Nephrology Dialysis Transplantation · 2022
- Cx43 Expression Correlates with Breast Cancer Metastasis in MDA-MB-231 Cells In Vitro, In a Mouse Xenograft Model and in Human Breast Cancer Tissues
Cancers · 2019
- Bevacizumab induces inflammation in MDA-MB-231 breast cancer cell line and in a mouse model
Cellular Signalling · 2018
- A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro
Biomedicine & Pharmacotherapy · 2018
- Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)
Data in Brief · 2018
- ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression
Retrovirology · 2016
- Journal of the American Society of Nephrology×10
- Cancers×2
- medRxiv×2
- Kidney International×1
- Nature Communications×1
- Jennifer L. Harder
Medicine · University of Michigan
- Chrysta Lienczewski
Medicine · University of Michigan
- Felix Eichinger
Medicine · University of Michigan
- Christopher L. O’Connor
Medicine · University of Michigan
- Mahboob Chowdhury
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile